Profil
Manish Tandon is currently Senior Vice President-Business Development at Ascentage Pharma Group International Co., Ltd. Formerly, Dr. Tandon was Senior Director-Business Development at ArQule, Inc. and Vice President-Business Development at InnoCare Pharma Ltd. Dr. Tandon completed a doctorate at Brown University, an undergraduate degree at the University of Delhi, and an MBA at Questrom School of Business.
Postes actifs de Manish Tandon
| Sociétés | Poste | Début |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Corporate Officer/Principal | - |
Anciens postes connus de Manish Tandon
| Sociétés | Poste | Fin |
|---|---|---|
| INNOCARE PHARMA LIMITED | Corporate Officer/Principal | - |
| ARQULE, INC. | Corporate Officer/Principal | - |
Formation de Manish Tandon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delhi
University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascentage Pharma Group International Co., Ltd.
Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Questrom School of Business
Questrom School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InnoCare Pharma Ltd.
InnoCare Pharma Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of cancer and autoimmune diseases | Health Technology |
















